Mindfulness App for Cancer Survivors
(SEAMLESS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a mindfulness app can assist cancer survivors after their main treatment concludes. Participants will use a smartphone app for about 20-30 minutes daily over four weeks to practice mindfulness, a mental exercise for focusing and relaxing the mind. The study will compare immediate app use with a group that waits three months before starting. Individuals who have completed their primary cancer treatment and can dedicate time daily to mindfulness activities are well-suited for this trial. As an unphased trial, this study provides participants the opportunity to explore innovative methods to enhance their well-being post-treatment.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, ongoing maintenance therapy, hormone-blocking therapies, and certain other treatments are allowed, so it's likely you can continue with your current medications.
What prior data suggests that this mindfulness app is safe for cancer survivors?
Research shows that mindfulness practices, like those in the app under study, are generally safe for cancer survivors. Studies have found that mindfulness can improve quality of life by reducing depression and anxiety in cancer patients. Evidence also suggests that mindfulness can help with fatigue and other cancer-related symptoms.
Importantly, these mindfulness practices are easy to manage and have not been linked to serious side effects. Therefore, for those considering joining this study, the mindfulness app is likely safe based on past research.12345Why are researchers excited about this trial?
Researchers are excited about the mindfulness app for cancer survivors because it offers a convenient, smartphone-based approach to mental well-being, unlike traditional in-person therapy sessions. This app delivers a structured mindfulness program that can be easily integrated into daily life, requiring only 20-30 minutes of activity on a minimum of four days per week. By making mindfulness practices accessible and flexible, the app has the potential to enhance mental health support for cancer survivors, offering benefits such as stress reduction, improved emotional regulation, and increased overall quality of life.
What evidence suggests that the Mindfulness app is effective for cancer survivors?
Research has shown that mindfulness activities can benefit cancer survivors. Studies have found that practicing mindfulness reduces stress and anxiety and improves overall well-being in cancer patients. For instance, patients have reported feeling more mindful, receiving more social support, and experiencing a greater sense of purpose and spirituality. Mindfulness also links to less fatigue and fewer other cancer-related symptoms. In this trial, participants in the "Immediate Mindfulness" arm will engage in a 4-week smartphone app-based mindfulness intervention program. App-based mindfulness programs, like the one under study, have shown promise in boosting mental health and quality of life for people living with cancer. Meanwhile, participants in the "Control Mindfulness" arm will initially receive no intervention and usual care for 4 weeks, followed by the same mindfulness program.16789
Who Is on the Research Team?
Linda E Carlson
Principal Investigator
University of Calgary
Are You a Good Fit for This Trial?
This trial is for English or French-speaking cancer survivors over 18 who've finished primary treatment at least 2 weeks ago. They must be willing to practice mindfulness daily using an app and have a smartphone with internet. It's not for those with cognitive impairments, weekly mindfulness experience, or current major depression.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 4-week smartphone app-based mindfulness intervention program
Waitlist Control
Participants in the control group wait for 3 months before receiving the intervention
Follow-up
Participants are monitored for stress, anxiety, depression, fatigue, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Mindfulness
Mindfulness is already approved in United States, European Union, Canada for the following indications:
- Substance Abuse Treatment
- Anxiety Disorders
- Depression
- Stress Management
- Anxiety Disorders
- Chronic Pain
- Depression
- Anxiety Disorders
- Substance Abuse Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Canadian Cancer Trials Group
Lead Sponsor
University of Calgary
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator